Ferozsons Laboratories Limited (PSX:FEROZ)

Pakistan · Delayed Price · Currency is PKR

334.35

-0.87 (-0.26%)

At close: Oct 19, 2026

Market Cap	14.53B -20.5%
Revenue (ttm)	23.96B +27.1%
Net Income	978.58M +26.0%
EPS	22.51 +26.0%
Shares Out	43.47M
PE Ratio	14.85
Forward PE	n/a
Dividend	5.50 (1.65%)
Ex-Dividend Date	Oct 20, 2026

Volume	2,358
Open	335.00
Previous Close	335.22
Day's Range	331.10 - 337.88
52-Week Range	293.01 - 475.00
Beta	0.56
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 29, 2026

About Ferozsons Laboratories

Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Sri Lanka, Afghanistan, Myanmar, the Philippines, Uzbekistan, Kyrgyzstan, Kenya, and internationally. The company provides products for various categories, including antibiotics, cardiology weight loss, oncology, hepatology, gastroenterology, urology, hair growth, cough syrups and lozenges, pain relief, anticoagulants, anti-inflammatory, hypertension, antiallergics, antianx... [Read more]

Industry Pharmaceuticals

Sector Healthcare

Founded 1894

Employees 1,676

Stock Exchange Pakistan Stock Exchange

Ticker Symbol FEROZ

Full Company Profile

Financial Performance

In fiscal year 2026, Ferozsons Laboratories's revenue was 23.96 billion, an increase of 27.05% compared to the previous year's 18.86 billion. Earnings were 978.58 million, an increase of 26.02%.

Financial Statements